Wednesday, March 17, 2021 11:38:09 AM
PDSB over 75 Million SHARES Traded since February 1st commenced there is about 14 million shares FLOATING. Lock up your shares Good till cancelled months out from today.
42% owned by insiders & institutions.
22 million shares minus shares owned by insiders & tutes
Equals less than 14 million shares Floating 111 million market cap tremendous upside 50x-100x ROI Potential in 2 years.
These MM are spoof trading this stock. Trying to rattle impatient folks. If you do the math there is really no liquid shares out there. They are trying so hard to accumulate this stock. I really believe we will be well into the double digits sooner than later.
The Covid Variant situation in Brazil and South America is spiraling out of control. This vaccine is worth 20 billion or more when approved late next year commercial ready in 2023 emergency EUA could be sooner.
Brazil’s rolling coronavirus disaster is a global problem
https://www.msn.com/en-us/news/world/brazil-e2-80-99s-rolling-coronavirus-disaster-is-a-threat-to-the-world/ar-BB1eFhPN
Bolsonaro’s Standing Craters Amid Historic Health-Care Collapse
https://www.bloombergquint.com/onweb/bolsonaro-s-rejection-soars-amid-historic-healthcare-collapse
PDSB has multi hundred dollar share price potential like NVAX or MRNA
PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technology and Innovation of Brazil (MCTI) to fund Clinical Development and Commercialization of PDS0203 with an Award of up to ~US$60 Million
https://www.pdsbiotech.com/investors/news-center/press-releases/press-releases1/113-2021-news/501-iotechnnouncesthatits19accineonsortium20210311n
PDSB Website
https://www.pdsbiotech.com/
PDSB March Biz Presentation
https://www.pdsbiotech.com/images/pdf/presentation/2021/march/PDSB_Corporate_Overview_-_March_11_2021_FINAL_1.pdf
PDSB Bleeding edge 2.0 Versamune®-based immunotherapies. technology for Cancer & infectious diseases This is a multibillion possibly double digit billion market cap in the making in the next 12-24 months buy and hold LONG TERM.
$PDSB
Recent PDSB News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:05:43 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 08:39:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:13:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:45:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 12:05:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:16:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:05:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:33:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 10:10:16 PM
- PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 01/22/2024 09:45:19 PM
- PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/04/2023 09:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:02:38 PM
- PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer • GlobeNewswire Inc. • 11/28/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 11:02:46 AM
- PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 12:30:55 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM